Literature DB >> 24559861

HIV-1 uncoating: connection to nuclear entry and regulation by host proteins.

Zandrea Ambrose1, Christopher Aiken2.   

Abstract

The RNA genome of human immunodeficiency virus type 1 (HIV-1) is enclosed by a capsid shell that dissociates within the cell in a multistep process known as uncoating, which influences completion of reverse transcription of the viral genome. Double-stranded viral DNA is imported into the nucleus for integration into the host genome, a hallmark of retroviral infection. Reverse transcription, nuclear entry, and integration are coordinated by a capsid uncoating process that is regulated by cellular proteins. Although uncoating is not well understood, recent studies have revealed insights into the process, particularly with respect to nuclear import pathways and protection of the viral genome from DNA sensors. Understanding uncoating will be valuable toward developing novel antiretroviral therapies for HIV-infected individuals.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Capsid; HIV-1; Human immunodefiency virus; Nuclear entry; Uncoating; Virus–host interactions

Mesh:

Year:  2014        PMID: 24559861      PMCID: PMC3988234          DOI: 10.1016/j.virol.2014.02.004

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  118 in total

1.  Hexagonal assembly of a restricting TRIM5alpha protein.

Authors:  Barbie K Ganser-Pornillos; Viswanathan Chandrasekaran; Owen Pornillos; Joseph G Sodroski; Wesley I Sundquist; Mark Yeager
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-27       Impact factor: 11.205

2.  Second-site compensatory mutations of HIV-1 capsid mutations.

Authors:  Colleen M Noviello; Claudia S López; Ben Kukull; Henry McNett; Amelia Still; Jacob Eccles; Rachel Sloan; Eric Barklis
Journal:  J Virol       Date:  2011-03-02       Impact factor: 5.103

3.  Complementary assays reveal a relationship between HIV-1 uncoating and reverse transcription.

Authors:  Amy E Hulme; Omar Perez; Thomas J Hope
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-31       Impact factor: 11.205

4.  Flexible use of nuclear import pathways by HIV-1.

Authors:  KyeongEun Lee; Zandrea Ambrose; Thomas D Martin; Ilker Oztop; Alok Mulky; John G Julias; Nick Vandegraaff; Joerg G Baumann; Rui Wang; Wendy Yuen; Taichiro Takemura; Kenneth Shelton; Ichiro Taniuchi; Yuan Li; Joseph Sodroski; Dan R Littman; John M Coffin; Stephen H Hughes; Derya Unutmaz; Alan Engelman; Vineet N KewalRamani
Journal:  Cell Host Microbe       Date:  2010-03-18       Impact factor: 21.023

5.  Small-molecule inhibition of human immunodeficiency virus type 1 infection by virus capsid destabilization.

Authors:  Jiong Shi; Jing Zhou; Vaibhav B Shah; Christopher Aiken; Kevin Whitby
Journal:  J Virol       Date:  2010-10-20       Impact factor: 5.103

6.  TRIM5alpha disrupts the structure of assembled HIV-1 capsid complexes in vitro.

Authors:  Lesa R Black; Christopher Aiken
Journal:  J Virol       Date:  2010-04-21       Impact factor: 5.103

7.  A cryptic sensor for HIV-1 activates antiviral innate immunity in dendritic cells.

Authors:  Nicolas Manel; Brandon Hogstad; Yaming Wang; David E Levy; Derya Unutmaz; Dan R Littman
Journal:  Nature       Date:  2010-09-09       Impact factor: 49.962

8.  HIV capsid is a tractable target for small molecule therapeutic intervention.

Authors:  Wade S Blair; Chris Pickford; Stephen L Irving; David G Brown; Marie Anderson; Richard Bazin; Joan Cao; Giuseppe Ciaramella; Jason Isaacson; Lynn Jackson; Rachael Hunt; Anne Kjerrstrom; James A Nieman; Amy K Patick; Manos Perros; Andrew D Scott; Kevin Whitby; Hua Wu; Scott L Butler
Journal:  PLoS Pathog       Date:  2010-12-09       Impact factor: 6.823

9.  Uncoating of human immunodeficiency virus type 1 requires prolyl isomerase Pin1.

Authors:  Shogo Misumi; Mutsumi Inoue; Takeo Dochi; Naoki Kishimoto; Naomi Hasegawa; Nobutoki Takamune; Shozo Shoji
Journal:  J Biol Chem       Date:  2010-06-07       Impact factor: 5.157

10.  Rhesus TRIM5α disrupts the HIV-1 capsid at the inter-hexamer interfaces.

Authors:  Gongpu Zhao; Danxia Ke; Thomas Vu; Jinwoo Ahn; Vaibhav B Shah; Ruifeng Yang; Christopher Aiken; Lisa M Charlton; Angela M Gronenborn; Peijun Zhang
Journal:  PLoS Pathog       Date:  2011-03-24       Impact factor: 6.823

View more
  96 in total

1.  Exploring Modifications of an HIV-1 Capsid Inhibitor: Design, Synthesis, and Mechanism of Action.

Authors:  Jimmy P Xu; Ashwanth C Francis; Megan E Meuser; Marie Mankowski; Roger G Ptak; Adel A Rashad; Gregory B Melikyan; Simon Cocklin
Journal:  J Drug Des Res       Date:  2018-08-13

2.  STRUCTURAL VIROLOGY. X-ray crystal structures of native HIV-1 capsid protein reveal conformational variability.

Authors:  Anna T Gres; Karen A Kirby; Vineet N KewalRamani; John J Tanner; Owen Pornillos; Stefan G Sarafianos
Journal:  Science       Date:  2015-06-04       Impact factor: 47.728

Review 3.  HIV-1 capsid: the multifaceted key player in HIV-1 infection.

Authors:  Edward M Campbell; Thomas J Hope
Journal:  Nat Rev Microbiol       Date:  2015-08       Impact factor: 60.633

Review 4.  Molecular dynamics simulations of large macromolecular complexes.

Authors:  Juan R Perilla; Boon Chong Goh; C Keith Cassidy; Bo Liu; Rafael C Bernardi; Till Rudack; Hang Yu; Zhe Wu; Klaus Schulten
Journal:  Curr Opin Struct Biol       Date:  2015-04-04       Impact factor: 6.809

5.  A Novel Phenotype Links HIV-1 Capsid Stability to cGAS-Mediated DNA Sensing.

Authors:  Mohammad Adnan Siddiqui; Akatsuki Saito; Upul D Halambage; Damien Ferhadian; Douglas K Fischer; Ashwanth C Francis; Gregory B Melikyan; Zandrea Ambrose; Christopher Aiken; Masahiro Yamashita
Journal:  J Virol       Date:  2019-07-30       Impact factor: 5.103

6.  HIV-1 uncoating occurs via a series of rapid biomechanical changes in the core related to individual stages of reverse transcription.

Authors:  Sanela Rankovic; Akshay Deshpande; Shimon Harel; Christopher Aiken; Itay Rousso
Journal:  J Virol       Date:  2021-03-10       Impact factor: 5.103

7.  Allosteric HIV-1 Integrase Inhibitors Lead to Premature Degradation of the Viral RNA Genome and Integrase in Target Cells.

Authors:  Michaela K Madison; Dana Q Lawson; Jennifer Elliott; Ayşe Naz Ozantürk; Pratibha C Koneru; Dana Townsend; Manel Errando; Mamuka Kvaratskhelia; Sebla B Kutluay
Journal:  J Virol       Date:  2017-08-10       Impact factor: 5.103

8.  PF74 Inhibits HIV-1 Integration by Altering the Composition of the Preintegration Complex.

Authors:  Muthukumar Balasubramaniam; Jing Zhou; Amma Addai; Phillip Martinez; Jui Pandhare; Christopher Aiken; Chandravanu Dash
Journal:  J Virol       Date:  2019-03-05       Impact factor: 5.103

9.  Design, Synthesis, and Mechanism Study of Benzenesulfonamide-Containing Phenylalanine Derivatives as Novel HIV-1 Capsid Inhibitors with Improved Antiviral Activities.

Authors:  Lin Sun; Alexej Dick; Megan E Meuser; Tianguang Huang; Waleed A Zalloum; Chin-Ho Chen; Srinivasulu Cherukupalli; Shujing Xu; Xiao Ding; Ping Gao; Dongwei Kang; Erik De Clercq; Christophe Pannecouque; Simon Cocklin; Kuo-Hsiung Lee; Xinyong Liu; Peng Zhan
Journal:  J Med Chem       Date:  2020-04-29       Impact factor: 7.446

Review 10.  HIV-1 Capsid Inhibitors as Antiretroviral Agents.

Authors:  Suzie Thenin-Houssier; Susana T Valente
Journal:  Curr HIV Res       Date:  2016       Impact factor: 1.581

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.